Please login to the form below

Not currently logged in
Email:
Password:

Exondys

This page shows the latest Exondys news and features for those working in and with pharma, biotech and healthcare.

Lilly links up with Precision BioSciences in genome editing deal

Lilly links up with Precision BioSciences in genome editing deal

Vyondys 53 is Sarepta’s second approved DMD therapy after Exondys 51 (eteplirsen).

Latest news

More from news
Approximately 4 fully matching, plus 18 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...